Evaluation of extraction kits and RT-qPCR systems adapted to high-throughput platform for circulating miRNAs

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Tan, Geok Wee ^a   Khoo, Alan Soo Beng ^a   Tan, Lu Ping ^a  

^a INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC KIT; MICRORNA;

DIAGNOSTIC KIT; GENETICS; HIGH THROUGHPUT SCREENING; HUMAN; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MICRORNAS; REAGENT KITS, DIAGNOSTIC; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84925373069     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09430     Document Type: Article

References (31)

1. Bartel, D. P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
2. Bartel, D. P. & Chen, C.-Z. Micromanagers of gene expression: The potentially widespread influence of metazoan micrornas. Nat Rev Genet 5, 396-400 (2004).
3. Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 105, 10513-10518 (2008).
4. Gilad, S. et al. Serum microRNAs are promising novel biomarkers. PLoS One 3, e3148 (2008).
5. Wang, K. et al. Comparing the microRNA spectrum between serum and plasma. PLoS One 7, e41561 (2012).
6. Carlsen, A. L. et al. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum 65, 1324-1334 (2013).
7. Jin, H., Li, C., Ge, H., Jiang, Y. & Li, Y. Circulating microRNA: A novel potential biomarker for early diagnosis of intracranial aneurysm rupture a case control study. J Transl Med 11, 296 (2013).
8. Wang, G.-K. et al . Circulating microRNA: A novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31, 659-666 (2010).
9. Zhi, F. et al. Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia. PLoS One 8, e56718 (2013).
10. Hardikar, A. A., Farr, R. J. & Joglekar, M. V. Circulating microRNAs: Understanding the limits for quantitative measurement by real-time PCR. J Am Heart Assoc 3, e000792 (2014).
11. Mestdagh, P. et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Meth 11, 809-815 (2014).
12. Dahl, A. et al. Quantitative PCR based expression analysis on a nanoliter scale using polymer nano-well chips. Biomed Microdevices 9, 307-314 (2007).
13. Spurgeon, S. L., Jones, R. C.&Ramakrishnan, R.High throughput gene expression measurement with real time PCR in a microfluidic dynamic array. PLoS ONE 3, e1662 (2008).
14. Gao, S., Chen, L.-Y., Wang, P., Liu, L.-M. & Chen, Z. MicroRNA expression in salivary supernatant of patients with pancreatic cancer and its relationship with ZHENG. BioMed Res Int 2014, 8 (2014).
15. Roberts, T. C. et al. Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover. Nucleic Acids Res 41, 9500-9513 (2013).
16. McDonald, J. S., Milosevic, D., Reddi, H. V., Grebe, S. K. & Algeciras-Schimnich, A. Analysis of circulatingmicro RNA: Preanalytical and analytical challenges. Clin Chem 57, 833-840 (2011).
17. Pritchard, C. C. et al. Blood cell origin of circulating microRNAs: A cautionary note for cancer biomarker studies. Cancer Prev Res 5, 492-497 (2012).
18. Kirschner, M. B. et al. Haemolysis during sample preparation alters microRNA content of plasma. PLoS One 6, e24145 (2011).
19. Duttagupta, R., Jiang, R., Gollub, J., Getts, R. C. & Jones, K. W. Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One 6, e20769 (2011).
20. Chim, S. S. et al. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 54, 482-490 (2008).
21. Witwer, K. W. Xenomirs and miRNA homeostasis in health and disease: Evidence that diet and dietary miRNAs directly and indirectly influence circulating miRNA profiles. RNA Biol 9, 1147-1154 (2012).
22. Sanz-Pamplona, R. et al. Clinical value of prognosis gene expression signatures in colorectal cancer: A systematic review. PLoS One 7, e48877 (2012).
23. Shi, L. et al. The microarray quality control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol 28, 827-838 (2010).
24. Kern, S. E. Why your new cancer biomarker may never work: Recurrent patterns and remarkable diversity in biomarker failures. Cancer Res 72, 6097-6101 (2012).
25. Moldovan, L. et al. Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med 18, 371-390 (2014).
26. Becker, C., Hammerle-Fickinger, A., Riedmaier, I. & Pfaffl, M. W. mRNA and microRNA quality control for RT-qPCR analysis. Methods 50, 237-243 (2010).
27. McAlexander, M. A., Phillips, M. J. &Witwer, K.W. Comparison of methods for miRNA extraction from plasma and quantitative recovery of RNA from plasma and cerebrospinal fluid. Front Genet 4, 83 (2013).
28. Kroh, E. M., Parkin, R. K., Mitchell, P. S. & Tewari, M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 50, 298-301 (2010).
29. Leung, A. K. L. & Sharp, P. A. MicroRNA functions in stress responses. Mol Cell 40, 205-215 (2010).
30. Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R.D.&Remaley, A. T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13, 423-433 (2011).
31. Heegaard, N. H. H. et al. Circulatingmicro-RNA expression profiles in early stage nonsmall cell lung cancer. Int J Cancer 130, 1378-1386 (2012).